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 ABSTRACT 
 The transition from the nonlactating to the lactating 
state represents a critical period for dairy cow lipid 
metabolism because body reserves have to be mobilized 
to meet the increasing energy requirements for the ini-
tiation of milk production. The purpose of this study 
was to provide a comprehensive overview on cholesterol 
homeostasis in transition dairy cows by assessing in 
parallel plasma, milk, and hepatic tissue for key factors 
of cholesterol metabolism, transport, and regulation. 
Blood samples and liver biopsies were taken from 50 
multiparous Holstein dairy cows in wk 3 antepartum 
(a.p.), wk 1 postpartum (p.p.), wk 4 p.p., and wk 14 
p.p. Milk sampling was performed in wk 1, 4, and 14 
p.p. Blood and milk lipid concentrations [triglycerides 
(TG), cholesterol, and lipoproteins], enzyme activities 
(phospholipid transfer protein and lecithin:cholesterol 
acyltransferase) were analyzed using enzymatic as-
says. Hepatic gene expression patterns of 3-hydroxy-
3-methylglutaryl-coenzyme A (HMGC) synthase 1 
(HMGCS1) and HMGC reductase (HMGCR), sterol 
regulatory element-binding factor (SREBF)-1 and -2, 
microsomal triglyceride transfer protein (MTTP), ATP-
binding cassette transporter (ABC) A1 and ABCG1, 
liver X receptor (LXR) α and peroxisome proliferator 
activated receptor (PPAR) α and γ were measured 
using quantitative RT-PCR. Plasma TG, cholesterol, 
and lipoprotein concentrations decreased from wk 3 
a.p. to a minimum in wk 1 p.p., and then gradually 
increased until wk 14 p.p. Compared with wk 4 p.p., 
phospholipid transfer protein activity was increased in 
wk 1 p.p., whereas lecithin:cholesterol acyltransferase 
activity was lowest at this period. Total cholesterol 
concentration and mass, and cholesterol concentration 
in the milk fat fraction decreased from wk 1 p.p. to wk 
4 p.p. Both total and milk fat cholesterol concentra-
tion were decreased in wk 4 p.p. compared with wk 1 
and 14 p.p. The mRNA abundance of genes involved 
in cholesterol synthesis (SREBF-2, HMGCS1, and 
HMGCR) markedly increased from wk 3 a.p. to wk 1 
p.p., whereas SREBF-1 was downregulated. The ex-
pression of ABCA1 increased from wk 3 a.p. to wk 
1 p.p., whereas ABCG1 was increased in wk 14 p.p. 
compared with other time points. In conclusion, he-
patic expression of genes involved in the biosynthesis 
of cholesterol as well as the ABCA1 transporter were 
upregulated at the onset of lactation, whereas plasma 
concentrations of total cholesterol, phospholipids, lipo-
protein-cholesterol, and TG were at a minimum. Thus, 
at the gene expression level, the liver seems to react to 
the increased demand for cholesterol after parturition. 
Whether the low plasma cholesterol and TG levels are 
due to impaired hepatic export mechanisms or reflect 
an enhanced transfer of these compounds into the milk 
to provide essential nutrients for the newborn remains 
to be elucidated. 
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 INTRODUCTION 
 Cholesterol and lipid metabolism have been widely 
investigated in humans and in rodent animal models as 
important factors contributing to lipid-associated dis-
eases, such as atherosclerosis or Tangier disease (Max-
field and Tabas, 2005). In dairy cows, an important 
lipid-related metabolic disorder is fatty liver (Grummer, 
1993). Particularly during the periparturient period 
lipid metabolism is challenged to ensure the increasing 
energy demands. Thus, adipose tissue is mobilized and 
the liver has to cope with an increasing supply of NEFA 
either by oxidation or by reesterification to triglycerides 
(TG; Grummer, 1993). Fatty liver develops when TG 
synthesis exceeds the export of TG as very low density 
lipoproteins (VLDL; Goff and Horst, 1997). 
 Lipoproteins are composed of a core of hydrophobic 
lipids (TG and cholesteryl esters) and an envelope con-
stituted of apoproteins and amphiphilic lipids (phos-
pholipids and free cholesterol). Hepatocytes secrete 
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cholesterol and TG in VLDL, which are processed in 
the circulation into intermediate-density lipoproteins 
by hydrolysis of the triglycerides. Intermediate-density 
lipoproteins are rich in cholesteryl esters and are ei-
ther metabolized to low density lipoproteins (LDL) or 
taken up by the liver. In humans, LDL are the main 
carriers of cholesterol in blood and deliver cholesterol 
from the liver to the peripheral tissues. Cholesterol 
is returned from extrahepatic tissues to the liver in 
high density lipoproteins (HDL) by reverse cholesterol 
transport.
Selective aspects of cholesterol metabolism in dairy 
cows have been a matter of intense investigation. Thus, 
bovine serum lipids and lipoproteins during gestation 
and lactation have been determined (Raphael et al., 
1973; Puppione et al., 1980) as well as the percentage 
of cholesterol in milk (Bitman and Wood, 1990). Genes 
involved in cholesterol synthesis, such as 3-hydroxy-
3-methylglutaryl-CoA reductase (HMGCR) and 
3-hydroxy-3-methylglutaryl-CoA synthase (HMGCS), 
and the regulation of the latter by sterol regulatory 
element-binding proteins (SREBP) in dairy cows have 
been recently assessed (Viturro et al., 2009; Schlegel 
et al., 2012). However, in those studies, only specific 
parameters of the complex network of cholesterol me-
tabolism were selectively highlighted or analysis was 
restricted to specific compartments (e.g., plasma), or 
both. Moreover, potential associations between the he-
patic activity and resulting effects on both plasma and 
milk cholesterol levels have been neglected so far.
Therefore, the purpose of the present study was to 
give a comprehensive overview of cholesterol metabo-
lism, transport, and hepatic regulatory genes in dairy 
cows during the transition period and until mid lacta-
tion at different regulatory and functional levels. To 
get insights into potential interactions between the 
liver and the mammary gland, plasma and milk cho-
lesterol contents were assessed in parallel in relation to 
endocrine factors, enzyme activities, and hepatic gene 
expressions of regulatory factors and enzymes.
MATERIALS AND METHODS
Animal Trial
The animal experiments were carried out at the Ag-
ricultural Experimental Unit Hirschau of the Technical 
University of Munich (Munich, Germany) and were 
approved by the responsible department for animal 
welfare affairs. Fifty multiparous Holstein dairy cows 
(parity 3.2 ± 0.2; mean ± SEM) were studied during 
a period from wk 3 antepartum (a.p.) to wk 14 post-
partum (p.p.). Cows were fed a mixed ration based on 
hay, grass, and corn silage for ad libitum intake and 
additional cereal-based concentrate according to milk 
production. The energy content of the mixed ration was 
6.53 ± 0.08 and 7.96 ± 0.04 MJ of NEL/kg of DM for 
the concentrates, respectively. The partial mixed ration 
had a crude fat content of 32 ± 6 and concentrates of 
24 ± 6 g/kg of DM, respectively. Details on the animal 
trial and the feeding regimen were described previously 
(Gross et al., 2011a).
Blood and Milk Sampling
Blood samples were collected from the jugular vein 
between 0730 and 0900 h before feeding in wk 3 a.p., 
wk 1 p.p., wk 4 p.p., and wk 14 p.p. The EDTA blood 
samples were immediately cooled down on wet ice, 
centrifuged at 2,000 × g for 15 min at 4°C and then 
aliquoted. Plasma samples were stored at −20°C until 
analysis.
Morning milk samples were collected once weekly at 
0500 h in wk 1 p.p., wk 4 p.p., and wk 14 p.p. and 
stored at −20°C until analysis.
Plasma Lipids
Concentrations of total cholesterol (TC) and TG 
were measured with enzymatic kits from bioMérieux 
SA (Geneva, Switzerland; no. 61219 for TC; no. 61236 
for TG). Concentrations of phospholipids (PL) and free 
cholesterol (FC) were measured with enzymatic kits 
from Wako Pure Chemical Industries Ltd. (Osaka, Ja-
pan; no. 296-63801 for PL; no. 435-35801 for FC). High 
density lipoprotein cholesterol (HDL-C) was measured 
with an immunoinhibition method (kit no. 412-72395) 
and LDL cholesterol (LDL-C) with an enzymatic kit 
(no. 419-24017) from Wako Chemical GmbH (Neuss, 
Germany).
Concentrations of cholesteryl esters (CE), VLDL 
cholesterol (VLDL-C), and LDL-C were calculated 
using the following equations:
Cholesteryl esters = total cholesterol  
− free cholesterol;
VLDL-C = triglycerides/5 (Friedewald et al., 1972);
LDL-C = total cholesterol − (HDL-C  
+ triglycerides/5) (Friedewald et al., 1972).
The LDL-C was additionally measured with an enzy-
matic kit (no. 419-24017) from Wako Chemical GmbH. 
The correlation between enzymatically measured and 
calculated LDL-C was 0.99 (P < 0.001).
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Plasma Enzyme Activities
Lecithin:cholesterol acyltransferase (LCAT) and 
phospholipid transfer protein (PLTP) activities in 
plasma were measured with fluorescence activity as-
says from Roar Biomedical Inc. (New York, NY; no. 
RB-LCAT; no. P7700) according to the manufacturer’s 
instructions. The LCAT activity is expressed as the 
ratio of the emissions of the substrate hydrolyzed to 
that not hydrolyzed.
Milk Cholesterol
Raw milk samples were thawed in a water bath and 
then put in an ultrasound bath for 5 min for homog-
enization. The methods described in Paradkar and Iru-
dayaraj (2002) and Kamelska et al. (2012) were modi-
fied as follows: 9 mL of ethanol and 1 mL of KOH (8.9 
M KOH solution) were added to 2 mL of raw milk and 
the mixture was vortexed for 20 s. Then, the capped 
test tube was placed in a water bath at 60°C, saponi-
fied, and stirred continuously at 200 rpm for 1 h. After 
cooling to room temperature, 5 mL of deionized water 
and 10 mL of hexane were added and vortexed for ap-
proximately 2 min. The sample was then centrifuged 
at 2,500 × g for 3 min at 4°C and the upper hexane 
layer was transferred into a new vial. The extraction 
process (10 mL of hexane) and centrifugation step 
(2,500 × g for 3 min at 4°C) were repeated, and the 
upper hexane layer was also transferred into the test 
tube. The hexane extract was evaporated to dryness in 
a water bath at 70°C and the sample was redissolved in 
2 mL of isopropanol. Total and free cholesterol in milk 
were measured with enzymatic kits (no. 61219 for TC) 
from bioMérieux SA and from Wako Pure Chemical 
Industries Ltd. (no. 435-35801 for FC) according to the 
manufacturers’ protocols.
Milk Fat Content
Milk fat concentrations were measured using an in-
frared analyzer (MilkoScan FT-6000; Foss Analytical 
A/S, Hillerød, Denmark) by the Milchprüfring Bayern 
e.V. (Wolnzach, Germany).
Liver Tissue Sampling and Hepatic Gene Expression
The liver was biopsied in parallel with blood sam-
pling in wk 3 a.p., wk 1 p.p., wk 4 p.p., and wk 14 p.p. 
under local anesthesia by needle biopsy as described by 
Gross et al. (2011b). Liver samples were put in RNA 
stabilization reagent (RNAlater; Ambion, Applied 
Biosystems Inc., Austin, TX), kept at +4°C for 24 h, 
and then stored at −20°C until analysis. Ribonucleic 
acid isolation was performed with peqGOLD TriFast 
reagent (PEQLAB Biotechnologie GmbH, Erlangen, 
Germany). The RNA integrity was verified by the opti-
cal density (OD) ratio at wavelengths of 260 and 280 
nm. All samples had an OD260:OD280 absorption ratio 
between 1.7 and 2.1. After reverse transcription of 1 
μg of total RNA into cDNA, PCR quantification of 
ATP-binding cassette transporter (ABC) A1, ABCG1, 
HMGCR, HMGCS1, liver X receptor α (LXRα), 
microsomal triglyceride transfer protein (MTTP), 
peroxisome proliferator-activated receptor (PPAR) 
α and γ, and sterol regulatory element-binding fac-
tor (SREBF)-1 and SREBF-2 genes was performed. 
Previous studies covering different metabolic stages in 
dairy cows showed that GAPDH and ubiquitin were 
stably expressed in the liver during the experiment 
(van Dorland et al., 2009; Graber et al., 2010; Gross 
et al., 2011b, 2013) and, thus, the mRNA abundance 
of the target genes was calculated in relation to their 
expression. The sizes of the obtained PCR products 
were verified on a gel. Details regarding the primers 
for the measured genes and methods used are given in 
Table 1 and in Gross et al. (2011b).
Statistical Analysis
Data presented in text and figures are means ± 
standard error of the means (SEM). The correlation 
between measured and calculated LDL cholesterol was 
evaluated with PROC CORR of SAS (version 9.2; SAS 
Institute Inc., Cary, NC).
To evaluate changes over time, data on plasma pa-
rameters, milk cholesterol, and hepatic mRNA abun-
dances at the respective time points in wk 3 a.p., wk 
1 p.p., wk 4 p.p., and wk 14 p.p. were evaluated by a 
MIXED model in SAS, with time point and parity as 
fixed effects. Differences over time were detected by the 
Bonferroni t-test at P < 0.05.
RESULTS
Plasma Lipids
The plasma concentrations of TC, CE, FC, PL, LDL-
C, and HDL-C (2.53 ± 0.06, 1.81 ± 0.05, 0.72 ± 0.02, 
1.31 ± 0.03, 1.40 ± 0.04, and 1.19 ± 0.02 mmol/L, re-
spectively) decreased from wk 3 a.p. to a nadir in wk 1 
p.p. (1.59 ± 0.05, 1.06 ± 0.04, 0.53 ± 0.01, 0.96 ± 0.03, 
0.69 ± 0.02, and 0.93 ± 0.03 mmol/L, respectively) and 
increased thereafter steadily until a maximum in wk 14 
p.p. (4.91 ± 0.12, 3.69 ± 0.09, 1.22 ± 0.03, 2.43 ± 0.05, 
2.86 ± 0.09, and 2.05 ± 0.04 mmol/L, respectively; 
Figures 1A–C).
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The concentrations of TG and VLDL-C in plasma 
decreased from a maximum in wk 3 a.p. (0.22 ± 0.01 
and 0.044 ± 0.001 mmol/L, respectively) to a minimum 
in wk 1 p.p. (0.11 ± 0.00 and 0.022 ± 0.001 mmol/L, 
respectively; Figures 1B and 1C). After parturition, 
the TG and VLDL-C concentrations increased steadily 
from wk 1 p.p. to wk 14 p.p. (0.13 ± 0.00 and 0.026 
± 0.001 mmol/L, respectively). The plasma concentra-
tions of measured and calculated LDL-C were highly 
correlated (r = 0.99; P < 0.001; data not shown).
Parity had a significant effect on plasma cholesterol 
(TC, FC, LDL-C, HDL-C, and CE) and PL concen-
trations (P < 0.0001). Cows with parity 2 and 3 had 
higher values for TC, FC, LDL-C, HDL-C, CE, and PL 
compared with cows with parity ≥4. All other factors 
determined in this study were not significantly affected 
by parity.
Plasma Enzyme Activities
Compared with the other time points, the plasma 
LCAT activity was lowest in wk 1 p.p. (ratio of 2.44 ± 
0.07; Figure 2). In contrast, the PLTP activity was el-
evated in wk 1 p.p. (45.67 ± 2.80 pmol) and decreased 
thereafter until wk 14 p.p. (31.32 ± 1.37 pmol; Figure 
2). Interestingly, the plasma activity of PLTP and 
LCAT showed an inverse pattern.
Milk Cholesterol
The concentration of TC in milk decreased from wk 
1 p.p. (0.32 ± 0.03 mmol/L) to wk 4 p.p. (0.18 ± 0.02 
mmol/L) and increased by trend in wk 14 p.p. (0.27 
± 0.02 mmol/L) to a lower concentration than in wk 
1 p.p. (P = 0.084; Figure 3A). The FC in milk fol-
lowed the pattern and concentration of TC, indicating 
that cholesterol in milk represents mostly FC (data not 
shown). The TC mass in milk was highest in wk 1 p.p. 
(2.26 ± 0.19 g) and decreased thereafter in wk 4 p.p. 
(1.55 ± 0.13 g; Figure 3A). In wk 14 p.p., the TC mass 
in milk increased by trend (1.88 ± 0.09 g; P = 0.066).
Cholesterol concentration in the milk fat fraction 
(mg of cholesterol per 100 g of fat) decreased from 
wk 1 p.p. (248.33 ± 18.27 mg of cholesterol/100 g of 
fat) to a minimum in wk 4 p.p. (171.55 ± 14.67 mg of 
cholesterol/100 g of fat) and increased thereafter in wk 
14 p.p. (272.35 ± 9.90 mg of cholesterol/100 g of fat; 
Figure 3B). Milk fat mass did not change from wk 1 
p.p. (919.53 ± 52.05 g) to wk 4 p.p. (937.93 ± 56.33 g), 
but decreased in wk 14 p.p. (687.35 ± 24.47 g; Figure 
3B).
Hepatic Gene Expression
The results of the gene expression measurements 
are summarized in Table 2. The expression of ABCA1 
Table 1. Nucleotide and PCR product specifications 
Gene1 Sequence 5c–3c
GenBank  
accession no.
Annealing  
temperature (°C)
Product  
length (bp)
ABCA1 Forward: GGACATGTGCAACTACGTGG NM_001024693 60 133Reverse: TGATGGACCACCCATACAGC
ABCG1 Forward: GACTCGGTCCTCACGCAC XM_587930 60 203Reverse: CGGAGAAACACGCTCATCTC
GAPDH Forward: TACATGGTCTACATGTTCCAGTATG NM 001034034 60 439Reverse: CAGTCTTCTGGGTGGCAGTGATG
HMGCR Forward: ACCCATGAGCGAGGTGTATC BC153262 63 241Reverse: TAGTGCTGGCCACAAGACAG
HMGCS1 Forward: TGTACGGCTCCCTGGCTTCTG BC102850 60 313Reverse: CATGTTCCTTCGAAGAGGGAATC
LXRα Forward: CTGCGATTGAGTGATGCTC NM_001014861.1 55 228Reverse: CGGTCTGCAGAGAAGATGC
MTTP Forward: TCATCCAATGTGGATGTCGC NM_001101834.1 58 267Reverse: GAGATTTTCTATGGCTGCTG
PPARα Forward: AGGGCTGCAAGGGTTTCTTTAG NM_001034036.1 60 363Reverse: TGACGAAAGGCGGGTTGTTGTTG
PPARγ Forward: AACTCCCTCATGGCCATTGAATG NM_181024.2 60 323Reverse: AGGTCAGCAGACTCTGGGTTC
SREBF1 Forward: CCAGCTGACAGCTCCATTGA NM_001113302.1 53 67Reverse: TGCGCGCCACAAGGA
SREBF2 Forward: GACTGATGCCAAGATGCACA XM_583656.3 60 140Reverse: CCCTTCAGGAGTTTGCTCTT
UBQ Forward: AGATCCAGGATAAGGAAGGCAT Z18245 62 198Reverse: GCTCCACTTCCAGGGTGAT
1ABCA1 = ATP-binding cassette transporter A1; ABCG1 = ATP-binding cassette transporter G1; HMGCR =3-hydroxy-3-methylglutaryl-CoA 
reductase; HMGCS1 = 3-hydroxy-3-methylglutaryl-CoA synthase 1; LXRα = liver X receptor α; MTTP = microsomal triglyceride transfer 
protein; PPARα = peroxisome proliferator-activated receptor α; PPARγ = peroxisome proliferator-activated receptor γ; SREBF-1 = sterol 
regulatory element-binding factor 1; SBREF-2 = sterol regulatory element-binding factor 2; UBQ = ubiquitin.
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showed an increase from wk 3 a.p. to wk 1 p.p. and 
remained thereafter on a comparable level, whereas the 
expression of ABCG1 was increased in wk 14 p.p. com-
pared with other time points (Table 2).The HMGCR 
and HMGCS1 mRNA abundances increased markedly 
from wk 3 a.p. to the lactational period, whereas the 
hepatic mRNA abundance of MTTP was not different 
between the measured time points (Table 2).
No differences in the hepatic expression of LXRα, 
PPARα, and PPARγ were found over time (Table 2). 
The mRNA abundance of SREBF-1 was lowest in wk 
1 p.p. compared with other time points, whereas the 
mRNA abundance of SREBF-2 increased from wk 3 
a.p. to wk 1 p.p. (Table 2).
DISCUSSION
In dairy cows, the transition period from the non-
lactating to the lactating state requires important 
homeorhetic changes (Bauman and Currie, 1980) to en-
able the shift of nutrients from body stores toward the 
mammary gland for milk production. In this context, 
not only glucose and lipid metabolism have to adapt 
to the lactating state, but also cholesterol metabolism. 
Thus, the aim of the present study was to comprehen-
sively investigate different compartments, regulatory 
components, and interactions mediating cholesterol 
homeostasis in dairy cows during the transition period 
until mid lactation.
3-Hydroxy-3-methylglutaryl-CoA reductase and 
HMGCS1 are key enzymes of the cholesterol biosyn-
thetic pathway and act as rate-controlling steps, with 
HMGCS producing the substrate for the HMGCR re-
action (Horton et al., 1998). In agreement with other 
studies (van Dorland et al., 2009; Viturro et al., 2009), 
HMGCR and HMGCS1 were markedly upregulated 
during early lactation compared with late pregnancy. 
The synthesis of sterols is controlled by SREBF-2 
(Horton et al., 1998). Sterol regulatory element-binding 
factors are synthesized as endoplasmic reticulum mem-
brane proteins. In the case of low cholesterol levels, 
Figure 1. Plasma concentration of total cholesterol (TC), cho-
lesteryl esters (CE), and free cholesterol (FC; A); very low density 
lipoprotein cholesterol (VLDL-C), low density lipoprotein cholesterol 
(LDL-C), and high density lipoprotein cholesterol (HDL-C; B); and 
triglycerides (TG) and phospholipids (PL; C) in cows from wk 3 an-
tepartum (a.p.) to wk 14 postpartum (p.p.). Significant changes over 
time are marked with different letters (a–d; P < 0.05). Data are shown 
as mean values ± SEM.
Figure 2. Plasma activity of phospholipid transfer protein (PLTP) 
and lecithin:cholesterol acyltransferase (LCAT) in cows from wk 3 
antepartum (a.p.) to wk 14 postpartum (p.p.). The LCAT activity is 
assessed as a ratio of the emissions of the substrate hydrolyzed to that 
not hydrolyzed. Significant changes over time are marked with differ-
ent letters (a–c; P < 0.05). Data are shown as mean values ± SEM.
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they migrate to the Golgi apparatus where they are 
cleaved and then released as nuclear SREBF able to 
activate target genes (Desvergne et al., 2006; Daemen 
et al., 2013). During this translocation, posttranscrip-
tional modifications of SREBF take place that might 
affect their further effects besides the mRNA expres-
sion level. In the present study, a significant increase 
in SREBF-2 mRNA abundance from pregnancy to the 
onset of lactation was observed emphasizing the regula-
tory function of SREBF-2 in cholesterol biosynthesis. 
Furthermore, SREBF-2 mRNA expression showed high 
and significant correlations with the hepatic gene ex-
pressions of HMGCR and HMGCS1 (data not shown).
Despite the apparently enhanced cholesterol syn-
thesis machinery at the onset of lactation, both TC 
concentration and individual lipoprotein-associated 
cholesterol fractions in the plasma (VLDL-C, LDL-C, 
and HDL-C) were dramatically decreased. Very low 
density lipoproteins are the most important carriers of 
TG in blood (Bauchart, 1993). During the early lacta-
tional negative energy balance, body fat reserves are 
mobilized and NEFA are transported to the liver where 
they are either oxidized or reesterified to TG. For the 
export from the liver, TG are packed in VLDL. MTTP 
is required for TG accumulation and apolipoprotein 
(apo) B lipidation during the assembly of VLDL (Ku-
linski et al., 2002). In the present study, hepatic mRNA 
abundance of MTTP was not affected during the entire 
experimental period, in contrast to an earlier study 
(Schlegel et al., 2012) where an increased expression 
of MTTP in wk 1 p.p. was observed. In the current 
investigation, and in agreement with Van den Top et 
al. (2005), VLDL-C and TG concentrations in plasma 
were distinctly decreased after parturition. Therefore, 
the secretion of VLDL from the liver might be limited 
at the onset of lactation and TG accumulate in the 
liver, leading to fatty liver, as confirmed by Gross et 
al. (2013).
Loor et al. (2007) hypothesized that cholesterol 
might be the limiting parameter of VLDL synthesis. 
However, the upregulation of the enzymes involved in 
cholesterol synthesis found in the present study as well 
as the high liver cholesterol concentration reported 
previously (Schlegel et al., 2012) suggest that this is 
unlikely. Furthermore, the upregulation of the HMGCR 
and HMGCS1 genes may be interpreted as a physiologi-
cal reaction to guarantee sufficient cholesterol supply 
for the production of VLDL; thus, enabling the export 
of TG from the liver. Van den Top et al. (1996) pro-
posed PL as the limiting factor for VLDL secretion, as, 
consistent with the present study, a decreased plasma 
concentration of PL was found after parturition. More-
over, the limited ability of ruminant hepatocytes to 
secrete VLDL (Kleppe et al., 1988; Pullen et al., 1990) 
may also contribute to the accumulation of TG in the 
liver.
In agreement with Van den Top et al. (2005), the 
LDL-C plasma concentration was decreased after 
parturition and steadily increased thereafter. The low 
plasma LDL-C concentration at the onset of lacta-
Table 2. Relative mRNA abundance [Δ cycle threshold (CT), log2] of genes analyzed in liver biopsies
1 
Parameter2
Time relative to parturition
wk 3 a.p. wk 1 p.p. wk 4 p.p. wk 14 p.p.
Cholesterol synthesis
 HMGCR 16.70 ± 0.30b 18.12 ± 0.26a 17.71 ± 0.22a 17.79 ± 0.24a
 HMGCS1 17.81 ± 0.31b 19.31 ± 0.30a 18.65 ± 0.22a 18.86 ± 0.22a
VLDL assembly
 MTTP 16.66 ± 0.17 17.03 ± 0.17 16.63 ± 0.18 16.79 ± 0.15
ABC transporter
 ABCA1 16.43 ± 0.31bc 17.26 ± 0.25a 16.90 ± 0.16ac 16.74 ± 0.24ac
 ABCG1 10.40 ± 0.35b 10.68 ± 0.22ab 10.53 ± 0.25b 11.26 ± 0.19a
Nuclear receptors
 LXRα 16.55 ± 0.12 16.53 ± 0.14 16.39 ± 0.13 16.48 ± 0.11
 PPARα 17.32 ± 0.12 17.35 ± 0.16 17.30 ± 0.16 17.38 ± 0.12
 PPARγ 10.90 ± 0.13 10.73 ± 0.14 10.55 ± 0.13 10.83 ± 0.15
Sterol regulatory element-binding factors
 SREBF-1 14.31 ± 0.18a 13.64 ± 0.14b 14.10 ± 0.15a 14.42 ± 0.14a
 SREBF-2 17.13 ± 0.27bc 17.83 ± 0.23a 17.62 ± 0.17ac 17.47 ± 0.23ac
a–cValues within a row with different superscript letters are significantly different (P < 0.05).
1Hepatic mRNA expression was analyzed in wk 3 antepartum (a.p.), wk 1 postpartum (p.p.), wk 4 p.p., and wk 14 p.p. Data are presented as 
means ± SEM. 
2HMGCR = 3-hydroxy-3-methylglutaryl-CoA reductase; HMGCS1 = 3-hydroxy-3-methylglutaryl-CoA synthase 1; VLDL = very low density 
lipoprotein; MTTP = microsomal triglyceride transfer protein; ABCA1 = ATP-binding cassette transporter A1; ABCG1 = ATP-binding cas-
sette transporter G1; LXRα = liver X receptor α; PPARα = peroxisome proliferator-activated receptor α; PPARγ = peroxisome proliferator-
activated receptor γ; SREBF-1 = sterol regulatory element-binding factor 1; SBREF-2 = sterol regulatory element-binding factor 2.
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tion might be a consequence of the low export rate 
of VLDL by the liver, as LDL arise from VLDL by 
receiving cholesteryl esters. Beside LDL-C, CE and FC 
plasma concentrations were lowest in the first week 
after parturition, and the cholesteryl esters:TC ratio 
was also decreased at the onset of lactation (data not 
shown) in line with a diminished activity of LCAT. 
Lecithin:cholesterol acyltransferase catalyzes the esteri-
fication of FC taken up from extrahepatic tissues by 
HDL with lecithin to produce cholesteryl esters. The 
reduced LCAT activity shortly after parturition was 
initially hypothesized to be a consequence of naturally 
occurring fatty liver (Nakagawa et al., 1997), but was 
also found in healthy cows with no fat infiltration of 
the liver (Pösö et al., 2000). Dairy cows included in the 
present study were attributed a “moderate fatty liver” 
(Gross et al., 2013) according to the classification given 
in Bobe et al. (2004). Thus, the decreased LCAT activ-
ity in this study at the onset of lactation might occur 
physiologically and could be additionally enforced by 
the development of fatty liver.
Phospholipid transfer protein has different physi-
ological functions, such as promoting the net transfer 
of phospholipids from VLDL toward HDL (Tall et al., 
1985). Phosphatidylcholines, a class of phospholipids, 
are the essential cholesterol-solubilizing components of 
HDL and the acyl donors for the esterification of FC 
into CE by LCAT (Rao et al., 1997). The elevated plas-
ma PLTP activity during the negative energy balance 
in early lactation could represent a physiological reac-
tion to counteract the low plasma cholesterol concen-
tration by providing substrate for the LCAT reaction 
and thereby increasing the CE production in plasma. 
Oram et al. (2003) demonstrated that PLTP can mimic 
HDL apolipoproteins in removing cholesterol and phos-
pholipids from cells by the ABCA1 pathway. The low 
plasma concentrations of TC and PL could, therefore, 
trigger the mobilization of cholesterol and PL by PLTP.
Cholesterol is transported from peripheral tissues to 
the liver by HDL. Nascent HDL particles are formed in 
the liver by the lipidation of apo A-I by the ABCA1 
pathway (Vaughan and Oram, 2006). Adenosine 
triphosphate-binding cassette transporter A1 plays a 
critical role in the efflux of cellular cholesterol to apo 
A-I (Oram and Heinecke, 2005). In the present study, 
the hepatic gene expression of ABCA1 was upregu-
lated in wk 1 p.p. compared with late pregnancy, in 
agreement with Schlegel et al. (2012). However, the 
upregulation of the ABCA1 gene was not reflected by 
an increased HDL-C concentration in plasma, as the 
latter decreased to a minimum at the onset of lactation. 
In general, the low HDL-C levels could have different 
reasons, such as decreased reverse cholesterol transport 
from extrahepatic tissues to the liver or a higher up-
take rate of HDL-C via the hepatic scavenger receptor 
class B type I (SR-BI) receptor. The upregulation of 
ABCA1 mRNA at the onset of lactation in the present 
study indicates that the ABCA1-mediated initiation 
of reverse cholesterol transport is not impaired (given 
that ABCA1 mRNA expression and protein activity 
correspond). Thus, it is likely that the HDL-C levels in 
the plasma are reduced due to either lower production 
of HDL-C from extrahepatic tissues, including other 
factors important for reverse cholesterol transport or 
higher clearance of HDL-C from the liver. Adenosine 
triphosphate-binding cassette transporter G1 is also 
involved in the export of cellular cholesterol and was 
shown to act in concert with ABCA1 to maximize the 
removal of excess cholesterol from cells (Vaughan and 
Oram, 2006). In contrast to ABCA1, the hepatic mRNA 
abundance of ABCG1 was elevated in mid lactation 
compared with earlier time points, a finding which was 
confirmed by a recent study (Schlegel et al., 2012). 
Thus, despite exerting similar physiological functions, 
the 2 cholesterol efflux proteins seem to be affected and 
Figure 3. Total cholesterol concentration and mass (g) in milk (A) 
and cholesterol concentration in milk fat (mg of cholesterol per 100 g 
of fat) and mass (g) of fat in milk (B) in cows from wk 1 postpartum 
(p.p.) to wk 14 p.p. Significant changes over time are marked with dif-
ferent letters (a and b; P < 0.05). Data are shown as mean values ± 
SEM. a.p. = antepartum.
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differentially regulated by the lactational stage. This 
could indicate that ABCA1 and ABCG1 may either 
have different functions during the pregnancy-lactation 
cycle and (or) that factors specific for the respective 
lactational stage differentially regulate their expression 
pattern in dairy cows. The molecular identity of these 
factors is currently unclear but it could be speculated 
that differential hormonal regulation or a potentially 
different apolipoprotein profile during the pregnancy-
lactation cycle may play a role.
Adenosine triphosphate-binding cassette transporter 
A1 and ABCG1 are target genes of the nuclear recep-
tor LXRα. Liver X receptor α functions as a sensor of 
cholesterol levels and is able to enhance the removal of 
cholesterol from cells by induction of ABC transporters 
(Schwartz et al., 2000; Desvergne et al., 2006). How-
ever, the mRNA abundance of LXRα was not altered 
between late pregnancy and lactation. Thus, other 
regulatory mechanisms than LXRα are involved in the 
regulation of the ABC transporters investigated in the 
present study. A regulating role could be assigned to 
SREBF-2, as this gene was highly correlated with both 
ABCA1 and ABCG1 expression (data not shown). In 
this context, also PPARα and γ were analyzed. Per-
oxisome proliferator-activated receptor α is involved 
in hepatic lipid catabolism through the activation of 
the β-oxidation pathway of NEFA in peroxisomes and 
mitochondria (Desvergne et al., 2006). In the present 
study, the mRNA abundance of PPARα was not af-
fected during the entire experimental period, even 
though cows had high plasma NEFA levels during early 
lactation (Gross et al., 2011a). In the study of van Dor-
land et al. (2009) the expression of PPARα did also 
not change, which was explained by the absence of a 
plasma NEFA peak, as Loor et al. (2005) had observed 
an upregulation of PPARα together with high NEFA 
concentrations. The mRNA abundance of PPARγ, a 
transcription factor that plays an adipogenic role in 
adipose tissue and to a lesser degree also in the liver 
(Desvergne and Wahli, 1999), was also unaffected by 
the lactational stage in the present investigation.
Another key factor in the hepatic transcriptional 
regulation of lipogenic enzymes is SREBF-1. Sterol 
regulatory element-binding factor 1 activates several 
genes involved in FA synthesis, such as acetyl-CoA car-
boxylase (ACC) or FA synthase (FASN; Shimano et al., 
1999). At the onset of lactation, the cows included in 
the present study experienced a hypoinsulinemic state 
(Gross et al., 2011b), and SREBF-1 was downregulated. 
Downregulation of SREBF-1 during early lactation was 
also observed by Graber et al. (2010) and is reflected 
by a reduced expression of ACC and FASN in the pe-
ripartal period (Gross et al., 2013). Sterol regulatory 
element-binding factor 1, in contrast to SREBF-2, is 
known to be stimulated by insulin, as both SREBF-1 
and insulin have been shown to induce lipogenesis 
(Daemen et al., 2013). Furthermore, insulin upregu-
lates HMGCR in vitro (Bhasker and Friedmann, 2008) 
and, in diabetic rats, insulin was able to restore the 
decreased HMGCR levels (Ness et al., 1994). However, 
these findings seem not to be applicable to dairy cows, 
as HMGCR and HMGCS1 were markedly upregulated 
after parturition, whereas the plasma insulin concentra-
tion was decreased (Gross et al., 2011b).
In dairy cows, the hypoinsulinemic state at the onset 
of lactation enables more glucose uptake by the mam-
mary gland (Bauman and Elliot, 1983). Apart from 
lactose, the main energy source for the offspring in milk 
are lipids. Most lipids are TG (97–98%), whereas PL 
(ca. 1%) and cholesterol (ca. 0.5%) represent just a 
small percentage that varies at different stages of lacta-
tion (Bitman and Wood, 1990; Jensen, 2002; Ontsouka 
and Albrecht, 2014). In agreement, TC concentration in 
milk was higher in wk 1 p.p. compared with wk 4 p.p. 
This was not a consequence of a higher dilution fac-
tor because of increasing milk yields, as also the mass 
of cholesterol transferred into milk was increased. The 
higher amount of cholesterol in the fat fraction in wk 1 
p.p. compared with wk 4 p.p. can be explained by an el-
evated fat content in wk 4 p.p. in parallel to low choles-
terol levels. Interestingly, the cholesterol concentration 
in milk reached its highest levels in wk 1 p.p. while in 
that period it was concomitantly lowest in blood. Only 
a small part of milk cholesterol originates from de novo 
synthesis in the mammary gland, whereas cholesterol 
uptake from the blood is far more pronounced (Long 
et al., 1980). It is likely that the high cholesterol mass 
in milk in wk 1 p.p. is partly responsible for the low 
cholesterol concentration in the blood. However, the el-
evated cholesterol mass in milk at the onset of lactation 
may be due to an increased apoptosis of mammary epi-
thelial cells (MEC) in the mammary gland. Mani et al. 
(2009) reported an upregulation of ABCA1 mRNA in 
mammary tissue at the end of the dry period compared 
with d 42 p.p., suggesting potential involvement of this 
transporter in the removal of cholesterol from MEC 
by efflux into milk. Mammary epithelial cell apoptosis 
is increased during late pregnancy and at the onset 
of lactation, leading to an accumulation of cholesterol-
rich debris in MEC (Annen et al., 2007; Mani et al., 
2009). Thus, the high cholesterol mass in milk during 
the first week of lactation might be supported by an 
increased efflux of cholesterol from the mammary gland 
by ABCA1. Furthermore, the localization pattern of 
the ABCA1 protein in MEC seems to depend on the 
functional stage of the mammary gland (Mani et al., 
2009; Mani et al., 2011). Thus, the varying localization 
of ABCA1 during the pregnancy-lactation cycle may 
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affect the cholesterol mass in milk at different stages 
of lactation.
CONCLUSIONS
The present comprehensive study investigates the 
interactions between cholesterol metabolism and 
transport at different functional levels and gives novel 
insights into the complex network of regulatory mecha-
nisms that are affected by the physiological stage of the 
dairy cow. At the onset of lactation, the hepatic gene 
expressions of key enzymes of cholesterol biosynthesis 
are upregulated to meet the increased cholesterol re-
quirements for exporting liver TG in the lactating dairy 
cow. However, the changes in hepatic gene expression 
are not reflected by an increase in the concentrations 
of lipoproteins and their components (TG, cholesterol, 
and PL) in plasma. These results indicate that the liver 
responds at the gene expression level accurately to the 
increased demand at the onset of lactation. Whether 
the low cholesterol and TG plasma levels are due to a 
compromised export rate from the liver, or represent a 
consequence of the increased transfer of these essential 
nutrients into milk for the offspring remains to be elu-
cidated.
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